30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

MUSCULOSKELETAL TRANSPLANT FOUNDATION (MTF) entered into an exclusive worldwide product license agreement with MEDARTIS covering certain ceramicbased products and technologies. medArtis produces hydroxyapatite (HA) and tricalcium phosphate (TCP) ceramic products through a proprietary processing technique that reportedly allows for the customization and control of pore structure, pore size and continuous connectivity. Under the terms of the agreement, medArtis will design, develop and manufacture ceramic constructs and other orthopaedic products, with MTF marketing and distributing them worldwide (excluding Austria, Germany, Liechtenstein and Switzerland). medArtis’ synthetic bone void fillers are CE-Marked. (Musculoskeletal Transplant Foundation, 5/5/03)